FDA Inspection
American National Red Cross (The)American National Red Cross (The) – FDA Inspection, Aug 2, 2013
Record Details
This FDA Inspection record concerns American National Red Cross (The), with an inspection on August 2, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 2, 2013
- Product Type
- Biologics
View Company Profile
ID · 451858fe-b5ee-4727-ad0e-4be0639ce249
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 840675
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American National Red Cross (The)
8| Date | Classification | Office | Project area |
|---|---|---|---|
| July 1, 2026 | Not classified | Minneapolis District Office | |
| April 12, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 31, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 26, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 26, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American National Red Cross (The)
- FDA Inspection 1328218 - 2026-07-01
- FDA Inspection 1089276 - 2019-04-12
- FDA Inspection 1027699 - 2017-08-31
- FDA Inspection 934759 - 2015-06-26
- FDA Inspection 897394 - 2014-09-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.